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DObjective:We seek to compare the early outcomes of frozen elephant trunk with total aortic arch replacement
using a 4-branched graft (the Sun procedure) in patients with acute and chronic type A aortic dissection (TAAD),
identify the risk factors for operative mortality, and determine whether the acuity of TAAD significantly affects
operative mortality.
Methods:We performed univariate and multivariate analyses of the clinical data from 803 patients with TAAD
who underwent the Sun procedure.
Results: The operative mortality was 6.5% (52 of 803). The overall incidence of stroke and spinal cord injury
was 2.0% (16 of 803) and 2.4% (19 of 803), respectively. Patients with acute TAAD had a greater incidence of
operative death (8.1% vs 4.3%; P ¼ .031), stroke (2.2% vs 0.6%; P ¼ .046), and respiratory morbidities
(20.8% vs 8.6%; P<.001). However, acuity was not identified as a risk factor for operative mortality (odds ratio
[OR], 1.67; P ¼ .152). The risk factors were previous cerebrovascular disease (OR, 7.01; P ¼ .001);
malperfusion of the brain (OR, 7.10; P ¼ .002), kidneys (OR, 12.67; P ¼ .005), spinal cord (OR, 22.79;
P ¼ .008), and viscera (OR 22.98; P ¼ .002); concomitant extra-anatomic bypass (OR, 9.50; P<.001); and
cardiopulmonary bypass time>180 minutes (OR, 1.01; P<.001).
Conclusions: In this group of patients with type A dissection, acuity was not a risk factor for operative mortality
after the Sun procedure. Patients with previous cerebrovascular disease; malperfusion of the brain, kidneys,
spinal cord, and/or viscera; concomitant extra-anatomic bypass; and a longer cardiopulmonary bypass time
(>180 minutes) were at greater risk of operative mortality. (J Thorac Cardiovasc Surg 2014;148:963-72)Stanford type A aortic dissection (TAAD) remains one of
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The Journal of Thoracic and Cacomplications resulting from hemorrhage or rupture are
most likely.1,2 Although the past 2 decades have seen
advances in surgical techniques and postoperative care,
evidence for improved outcomes has been modest,3 and
several contentious issues remain in the surgical treatment
of patients with TAAD. The most fundamental issue is the
optimal surgical approach, especially the extent of the distal
aortic repair.4-6 Some surgeons have advocated a more
limited approach, such as ascending aortic or hemiarch
repair,6 and others have supported the frozen elephant trunk
(FET) technique,7-9 which has considerably improved the
clinical outcomes of TAADs involving the aortic arch and
proximal descending aorta.10,11 However, surgical opinion
has been divided on the use of this extensive approach for
patients with TAAD.3,7,8,12,13 The event of acute
dissection itself is the dominant risk factor, just as is the
need for preoperative resuscitation.3,14 This raises another
concern that surgical repair in the acute phase is
associated with greater operative mortality than in the
chronic phase, which was evidenced by the report of Safi
and colleagues,1 which showed an operative mortality of
20% in those with acute and 4% in those with chronic
TAAD.
For those reasons, we retrospectively analyzed the early
outcomes of FET with total aortic arch replacement using
a 4-branched graft (ie, the Sun procedure)15-18 in 803rdiovascular Surgery c Volume 148, Number 3 963
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
FET ¼ frozen elephant trunk
OR ¼ odds ratio
TAAD ¼ type A aortic dissection
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compared the early outcomes between the acute and
chronic TAAD groups after the Sun procedure to identify
the risk factors for operative mortality in both groups and
whether the acuity of aortic dissection significantly affects
the operative mortality with this extensive surgical
approach for TAADs.
METHODS
The ethics committees of Fu Wai Hospital and Cardiovascular Institute
and Beijing Anzhen Hospital, Capital Medical University approved the
present retrospective study.
Patients
From April 2003 to September 2012, our group performed the Sun
procedure for 803 patients with TAAD. Their mean age was 46.1  10.8
years (range, 17-78), and 640 (79.7%) were male. Based on the interval
between symptom onset and surgery,2 acute TAAD (14 days) was
diagnosed in 456 patients and chronic TAAD (>14 days) in 347. In those
with acute TAAD, the interval was 5.0  3.8 days (median, 4; range, 5
hours to 14 days). Also, within the first 10 hours after dissection onset,
30 of the 456 patients (6.6%) presented and 6 (1.3%) underwent surgery.
The median interval from symptom onset to surgery in those with
chronic TAAD was 37 days (mean, 189; range, 14.2 days to 10 years).
A preoperative diagnosis of TAAD was confirmed by transthoracic
echocardiography or computed tomographic angiography in all patients.
A total of 101 cases (12.6%) of clinically apparent malperfusion
occurred in 88 patients (10.9%), with 56 (12.3%) and 32 (9.2%) in the
acute and chronic groups, respectively. Lower limb malperfusion was
most common (6.0%, 48 of 803), followed by cerebral (2.6%, 21 of
803), coronary (1.7%, 14 of 803), renal (0.9%, 7 of 803), and visceral
ischemia (0.9%, 7 of 803; Table 1).
Selection Criteria
In patients with TAAD, the Sun procedure was indicated in any of the
following pathologic conditions: (1) primary entry located in the arch or de-
scending aorta; (2) severe arch vessel pathologic features, including dissec-
tion, occlusion, stenosis, or aneurysm changes; (3) intimal intussusception
in the arch; (4) concomitant Marfan syndrome; and (5) dissection in a
dilated arch>4 cm in diameter and extending beyond the descending
aorta.19 For patients with none of these conditions, a different approach
would be proposed, such as ascending aortic or hemiarch repair or total
arch repair without FET.20 For patients with TAADwho had the pathologic
indications but developed malperfusion preoperatively, this procedure
would still be performed, as long as no end-organ failure had occurred,
such as coma, paraplegia, hemiplegia, intestinal necrosis, or hepatic failure.
Senior age was not a contraindication.
Surgical Techniques
The Sun procedure refers to total aortic arch replacement using a
4-branched vascular graft combined with implantation of a specially
designed FET into the descending aorta.15-18 The surgical technique has964 The Journal of Thoracic and Cardiovascular Surgbeen previously described in detail.15-23 In brief, it is performed with right
axillary artery cannulation for cardiopulmonary bypass (CPB) and selective
antegrade cerebral perfusion, under moderate hypothermic circulatory
arrest at 25C. The procedure involves implantation of an FET (Cronus;
MicroPort Medical Co, Ltd, Shanghai, China) in the descending aorta,
followedby total arch replacementwith a 4-branchedvasculargraft.A special
sequence is used for aortic reconstruction (ie, proximal descending aorta, then
left carotid artery, then ascending aorta, then left subclavian artery, and,
finally, innominate artery). Early rewarming and reperfusion is performed
after the distal anastomosis to minimize the cerebral and coronary ischemia.
Associated operations, such as aortic root replacement or coronary artery
bypass grafting, are performed during the cooling phase, if indicated.
Definition of Outcomes and Risk Factors
The endpoint was operative mortality, including all deaths, regardless of
cause, occurring during the same hospitalization in which the operation
was performed, even if after 30 days; and after discharge from the hospital
but within 30 postoperative days. Stroke was defined as any confirmed
neurologic deficit of abrupt onset caused by a disturbance in blood supply
to the brain lasting>24 hours. Coronary artery disease was documented by
preoperative computed tomographic angiography or from a history of
myocardial infarction or coronary angiographic findings, or percutaneous
coronary interventions. Renal failure was defined as an increase in serum
creatinine of 1 mg/dL greater than baseline or a new requirement for renal
dialysis. Malperfusion syndrome was defined as end-organ ischemia
caused by branch vessel involvement and resulting in clinical symptoms
and functional impairment.
Statistical Analysis
The datawere analyzed using the Statistical Package for Social Sciences
for Windows, version 13.0 (SPSS Inc, Chicago, Ill). Data are expressed as
the mean standard deviation or percentages and were compared using the
Student t test, Pearson chi-square test, or Fisher exact test, as appropriate.
Univariate analysis was used to evaluate variables that could affect
operative mortality in both groups. Variables with P<.05 on univariate
analysis were assessed with multivariate analysis using a forward stepwise
binary logistic regression model. All statistical tests were 2-sided.RESULTS
Operative Data
The location of an intimal tear was confirmed during
surgery (Table 2). An intimal tear in the aortic arch was
found only in the patients with acute TAAD (n ¼ 92,
20.2%). The patients with chronic TAAD had more tears
in the descending aorta (106 of 347, 30.5%) than did those
with acute TAAD (101 of 456, 22.1%; P ¼ .007) and had
more unidentifiable tears (43 of 347, 12.4%) than did those
with acute TAAD (17 of 456, 3.7%; P>.001). Aortic root
or valve procedures were performed in 221 patients
(48.5%) with acute and 163 patients (47.0%) with chronic
TAAD, including aortic valve repair in 63 (13.8%) and
22 (6.3%; P ¼ .001) and the Bentall operation in 130
(28.5%) and 119 (34.3%), respectively. A total of 109
concomitant operations were done in 102 patients
(12.7%), including coronary artery bypass grafting in 43
(9.4%) and 24 (6.9%), extra-anatomic bypass in 11
(2.5%) and 16 (4.6%), and mitral valve surgery in 2
(0.4%) and 13 (3.7%) patients in the acute and chronic
groups, respectively. The CPB, crossclamp, and selectiveery c September 2014
TABLE 1. Preoperative clinical profiles
Variable
Acute
(n ¼ 456)
Chronic
(n ¼ 347)
P
value
Age (y) 46.2  10.5 45.9  11.2 .063
Age group (y) .750
<40 126 (27.6) 100 (28.8) .711
40-49 156 (34.2) 112 (32.3) .565
50-59 127 (27.9) 92 (26.5) .673
60 47 (10.3) 43 (12.4) .554
Sex .026
Male 376 (82.5) 264 (76.1)
Female 80 (17.5) 83 (23.9)
Comorbidities
Hypertension 333 (73.0) 228 (65.7) .025
Marfan syndrome 34 (7.5) 52 (15.0) .001
Diabetes mellitus 14 (3.1) 10 (2.9) .877
Coronary artery disease 18 (3.9) 31 (8.9) .003
Cerebrovascular disease 12 (2.6) 11 (3.2) .650
Chronic kidney disease 10 (2.2) 10 (2.9) .535
Congestive heart failure 1 (0.2) 2 (0.6) .812
Malperfusion syndrome* 56 (12.3) 32 (9.2) .169
Cerebral malperfusion 13 (2.8) 8 (2.3) .631
Coronary malperfusion 9 (2.0) 5 (1.4) .568
Renal malperfusion 7 (1.5) 0 (0) .053
Spinal cord malperfusion 3 (0.6) 1 (0.3) .817
Visceral malperfusion 6 (1.3) 1 (0.3) .243
Lower limb malperfusion 27 (5.9) 21 (6.0) .938
2 Organs 8 (1.8) 4 (1.2) .486
Acute heart failure 7 (1.5) 0 (0) .053
Cardiac tamponade 15 (3.3) 1 (0.3) .003
Data presented as mean standard deviation or n (%). *Number of patients in whom
clinically apparent malperfusion occurred; malperfusion of 2 organs expressed by
the number of cases that actually occurred.
TABLE 2. Operative data
Variable
Acute
(n ¼ 456)
Chronic
(n ¼ 347)
P
value
Intraoperative findings
Location of intimal tear <.001
Ascending aorta 202 (44.3) 152 (43.8) .889
Transverse arch 92 (20.2) 0 (0) <.001
Descending aorta 101 (22.1) 106 (30.5) .007
Multiple locations 44 (9.6) 46 (13.3) .108
Unidentified 17 (3.7) 43 (12.4) <.001
Procedural times
Cardiopulmonary bypass time (min) 199  50 184  52 <.001
>180 min 274 (60.1) 165 (47.6) <.001
Crossclamp time (min) 112  47 98  29 <.001
>100 min 250 (54.8) 136 (39.2) <.001
Selective cerebral perfusion time (min) 25  8 24  8 .038
>25 min 157 (34.4) 108 (31.1) .115
Aortic valve or root procedures 221 (48.5) 163 (47.0) .782
Aortic valve repair 63 (13.8) 22 (6.3) .001
Repair of sinus of Valsalva 19 (4.2) 6 (1.7) .049
David procedure 1 (0.2) 0 (0) .999
Aortic valve replacement 5 (1.1) 5 (1.4) .909
Bentall procedure 130 (28.5) 119 (34.3) .079
Cabrol procedure 1 (0.2) 5 (1.4) .115
Wheat procedure 2 (0.4) 6 (1.7) .143
Concomitant procedures* 53 (11.6) 49 (14.1) .292
Coronary artery bypass grafting 43 (9.4) 24 (6.9) .202
Extra-anatomic bypass 11 (2.4) 16 (4.6) .087
Ascending aortic-to-femoral 6 (1.3) 9 (2.6) .185
Ascending aortic-to-axillary 1 (0.2) 0 (0.0) .999
Ascending-to-abdominal aortic 1 (0.2) 2 (0.6) .812
Femoral-to-femoral 3 (0.7) 4 (1.2) .716
Axillary-to-femoral 0 (0) 1 (0.3) .432
Mitral valve operation 2 (0.4) 13 (3.7) .001
Replacement 2 (0.4) 10 (2.9) .005
Repair 0 (0) 3 (0.9) .160
Selective cerebral perfusion time refers to the interval from initiation of hypothermic
circulatory arrest to completion of left carotid anastomosis, which is longer than the
time for deep hypothermic circulatory arrest, when lower body perfusion is arrested to
implant the frozen elephant trunk and suture the proximal descending anastomosis.
*Number of patients in whom concomitant procedures were performed; specific
procedures are expressed by the number of cases.
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longer than the those in the chronic group (199 50 vs 184
 52 minutes, P< .001; 112  47 vs 98  29 minutes,
P < .001; and 25  8 vs 24  8 minutes, P ¼ .038,
respectively). Prolonged aortic crossclamp (>100 minutes)
and CPB (>180 minutes) times occurred predominantly in
the acute group (P<.001).
Operative Mortality and Morbidity
The overall operative mortality was 6.5% (52 of 803),
including 15 deaths (4.3%) in the chronic and 37 (8.1%)
in the acute group, respectively (P ¼ .031). The leading
cause of death was multiorgan failure, identified in 24 of
the 52 patients (46.2%); of the 24 deaths, 16 were in the
acute TAAD group (3.5% of 456). Stroke and low cardiac
output syndrome led to 9 (2.0%) and 7 (1.5%) deaths in
the acute group compared with 1 (0.3%) and 3 (0.9%)
deaths in the chronic group. Three patients (0.4%) died of
acute renal failure. Other causes of death included
respiratory failure, cardiac arrest, mediastinal infection,
abdominal aortic rupture, and coagulopathy (n ¼ 1 for
each; Table 3).The Journal of Thoracic and CaPatients with malperfusion had an overall mortality of
19.3% (17 of 88), predominantly in the acute group
(25.0%, 14 of 56 vs 9.4%, 3 of 32; P<.001). The major
reasons were multiorgan failure in 8, stroke in 4, low
cardiac output syndrome in 2, and acute renal failure in 2.
Malperfusion of 2 organs occurred in 8 (1.8%) and 4
(1.2%) patients in the acute and TAAD groups,
respectively, with 5 deaths (62.5%) exclusively in the acute
group (Table 4).
The operative mortality rate did not differ significantly,
either among 4 age groups in the acute (P ¼ .185) and
chronic (P¼ .927) groups or between the acute and chronic
groups in the 4 age groups (P> .05). Patients with acute
TAAD who were 60 had a mortality of 12.8% (6 of 47),rdiovascular Surgery c Volume 148, Number 3 965
TABLE 3. Operative mortality and morbidity
Variable
Acute
(n ¼ 456)
Chronic
(n ¼ 347)
P
value
Mortality 37 (8.1) 15 (4.3) .031
Multiorgan failure 16 (3.5) 8 (2.3) .321
Stroke 9 (2.0) 1 (0.3) .070
Low cardiac output syndrome 7 (1.5) 3 (0.9) .598
Acute renal failure 2 (0.4) 1 (0.3) 1.000
Abdominal aortic rupture 0 (0) 1 (0.3) .432
Cardiac arrest 0 (0) 1 (0.3) .432
Respiratory failure 1 (0.2) 0 (0) 1.000
Mediastinal infection 1 (0.2) 0 (0) 1.000
Coagulopathy 1 (0.2) 0 (0) 1.000
Morbidity
Neurologic 28 (6.1) 16 (4.6) .345
Stroke 13 (2.8) 3 (0.9) .046
Spinal cord injury 11 (2.4) 8 (2.3) .941
Paraplegia 7 (1.5) 2 (0.6) .201
Paraparesis 4 (0.9) 6 (1.7) .449
Recurrent laryngeal nerve injury 4 (0.9) 5 (1.4) .679
Pulmonary* 95 (20.8) 30 (8.6) <.001
Prolonged ventilation 84 (18.4) 26 (7.5) <.001
Reintubation 33 (7.2) 12 (3.5) .021
Pneumonia 8 (1.8) 2 (0.6) .242
Pleural effusion 2 (0.4) 0 (0) .509
Pneumothorax 1 (0.2) 1 (0.3) 1.000
Renal failure 18 (3.9) 9 (2.6) .292
Low cardiac output syndrome 7 (0.8) 6 (1.7) .829
Limb ischemia 3 (0.7) 4 (1.2) .716
Reintervention 20 (4.4) 20 (5.8) .374
Reexploration for bleeding 10 (2.2) 15 (4.3) .085
Pericardial drainage for effusion 5 (1.1) 2 (0.6) .687
Thoracoabdominal aortic replacement 0 (0) 2 (0.6) 1.000
Endovascular stent grafting for distal tear 2 (0.4) 1 (0.3) 1.000
Axillary-to-axillary bypass 1 (0.2) 0 (0) 1.000
Amputation 1 (0.2) 0 (0) 1.000
Redo Bentall procedure 1 (0.2) 0 (0) 1.000
*Number of patients in whom pulmonary complications occurred; specific
morbidities are expressed by the number of cases that actually occurred.
TABLE 4. Mortality in patients with malperfusion syndrome
Pt. no. Acuity Malperfusion type Cause of death
1 Acute Renal Acute renal failure
2 Acute Renal, cerebral, visceral Multiple organ failure
3 Acute Spinal cord, lower limb Stroke
4 Acute Visceral Stroke
5 Acute Cerebral, visceral Multiple organ failure
6 Acute Spinal cord, lower limb Multiple organ failure
7 Acute Lower limb Multiple organ failure
8 Acute Cerebral, visceral Multiple organ failure
9 Acute Cerebral Low cardiac output syndrome
10 Acute Coronary Low cardiac output syndrome
11 Acute Cerebral Stroke
12 Acute Renal Acute renal failure
13 Acute Coronary Coagulopathy
14 Acute Coronary Multiple organ failure
15 Chronic Cerebral Multiple organ failure
16 Chronic Visceral Multiple organ failure
17 Chronic Cerebral Stroke
Pt. no., Patient number.
TABLE 5. Operative mortality specific to age group in acute and
chronic groups
Acuity
Age group-specific mortality
(deaths/total patients) P
value<40 y 40-49 y 50-59 y 60 y
Acute
(n ¼ 37)
9/126 (7.1) 8/156 (5.1) 14/127 (11.0) 6/47 (12.8) .185
Chronic
(n ¼ 15)
4/100 (4.0) 4/112 (3.6) 5/92 (5.4) 2/43 (4.7) .927
P value* .314 .543 .147 .327 —
Data in parentheses are percentages. *Comparison of mortality in any age group
between acute and chronic groups.
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statistical significance (P ¼ .185; Table 5).
The patients with acute TAAD had a greater incidence of
stroke (13 of 456, 2.2%, vs 3 of 347, 0.6%; P ¼ .046) and
respiratory complications (95 of 456, 20.8%, vs 30 of 347,
8.6%; P<.001). The overall incidence of stroke and spinal
cord injury was 2.0% (16 of 803) and 2.4% (19 of 803),
respectively. Stroke occurred in 13 (2.2%) and 3 (0.6%;
P ¼ .046) and caused 9 (69.2%) and 1 (33.3%) deaths in
the acute and chronic groups, respectively. Spinal cord
injury occurred in 11 (2.4%) and 8 (2.3%) patients with
acute and chronic TAAD, respectively (P>.05), including
paraplegia in 7 (1.5%) and 2 (0.6%) and paraparesis in 4
(0.9%) and 6 (1.7%). Albeit present only in 13 (1.6%) of
the 803 patients, low cardiac output syndrome caused 7 of
7 deaths (100%) in the acute and 3 of 6 (50.0%) in the966 The Journal of Thoracic and Cardiovascular Surgchronic groups. Renal failure occurred in 27 (3.4%), with
18 (3.9%) in the acute and 9 (2.6%) in the chronic group
(P>.05). The overall incidence of recurrent laryngeal nerve
injury and limb ischemia was 1.1% (9 of 803) and 0.9%
(7 of 803), respectively. Prolonged ventilation>48 hours
was required in 84 patients (18.4%) in the acute versus
26 (7.5%) in the chronic group (P < .001). Tracheal
reintubation occurred in 33 (7.2%) with acute and 12
(3.5%) with chronic TAAD (P ¼ .021). Pneumonia
occurred in 10 patients (1.2%), pneumothorax in 2
(0.2%), and pleural effusion in 2 (0.2%; Table 3).
Postoperative reintervention was required in 40 patients
(5.0%), 20 in each group. Reexploration for bleeding was
required in 25 patients (3.1%), and drainage of pericardial
effusion in 7 (0.9%). An intimal tear at the distal end of the
open stent graft necessitated endovascular stent grafting in 3
cases. Other reoperations included thoracoabdominal aortic
repair in 2 patients with chronic TAAD, a redo Bentall
procedure for aortic root bleeding in 1, an axillary to axil-
lary bypass for left arm ischemia in 1, and an amputation
for left leg thrombotic necrosis in 1 (Table 3).ery c September 2014
TABLE 6. Univariate analysis of operative mortality in acute and
chronic groups
Variable
Acute
(n ¼ 456)
Chronic
(n ¼ 347)
P
value
Acuity group 37/419 (8.8) 15/347 (4.5) .031
Sex .104
Male 35/376 (9.3) 11/264 (4.2)
Female 2/80 (2.5) 4/83 (4.8)
Hypertension .404
Yes 29/333 (8.7) 10/228 (4.4)
No 8/123 (6.5) 5/119 (4.2)
Marfan syndrome .234
Yes 2/34 (5.9) 1/52 (1.9)
No 35/422 (8.3) 14/295 (4.7)
Diabetes mellitus .191
Yes 0/14 (0) 0/10 (0)
No 37/442 (8.4) 15/337 (4.5)
Coronary artery disease .917
Yes 1/18 (5.6) 2/31 (6.5)
No 36/438 (8.2) 13/316 (4.1)
Chronic heart failure .648
Yes 0/1 (0) 0/2 (0)
No 37/455 (8.1) 15/345 (4.3)
Cerebrovascular disease .031
Yes 4/12 (33.3) 0/11 (0)
No 33/444 (7.4) 15/336 (4.5)
Chronic renal failure .786
Yes 0/10 (0) 1/10 (10.0)
No 37/446 (8.3) 14/337 (4.2)
Malperfusion (as an entity) <.001
Yes 14/56 (25.0) 3/32 (9.4)
No 23/400 (5.8) 12/315 (3.8)
Renal malperfusion <.001
Yes 3/7 (42.9) 0/0 (0)
No 34/449 (7.6) 15/347 (4.3)
Coronary malperfusion .022
Yes 3/9 (33.3) 0/5 (0)
No 34/447 (7.6) 15/342 (4.4)
Cerebral malperfusion <.001
Yes 5/13 (38.5) 2/8 (25.0)
No 32/443 (7.2) 13/339 (3.8)
Spinal cord malperfusion <.001
Yes 2/3 (66.7) 0/1 (0)
No 35/453 (7.7) 15/346 (4.3)
Visceral malperfusion <.001
Yes 4/6 (66.7) 1/1 (100)
No 33/450 (7.3) 14/346 (4.0)
Lower limb malperfusion .948
Yes 3/27 (11.1) 0/21 (0)
No 34/429 (7.9) 15/326 (4.6)
Malperfusion of 2 organs <.001
Yes 5/8 (62.5) 0/4 (0)
No 32/448 (7.1) 15/343 (4.4)
Acute heart failure .017
Yes 2/7 (28.6) 0/0 (0)
No 35/449 (7.8) 15/347 (4.3)
(Continued)
TABLE 6. Continued
Variable
Acute
(n ¼ 456)
Chronic
(n ¼ 347)
P
value
Cardiac tamponade .002
Yes 4/15 (26.7) 0/1 (0)
No 33/441 (7.5) 15/346 (4.3)
Location of intimal tear
Ascending aorta 15/202 (7.4) 7/152 (4.6) .479
Aortic arch 9/92 (9.8) 0/0 (0) .790
Descending aorta 9/101 (8.9) 6/106 (5.7) .171
Multiple tears 4/44 (9.0) 0/46 (0) .601
Unidentified 0/17 (0) 2/43 (4.7) .406
Selective cerebral perfusion time .575
>25 min 14/157 (8.9) 5/108 (4.6)
<25 min 23/299 (7.7) 10/239 (4.2)
Crossclamp time .022
>100 min 24/250 (9.6) 9/136 (6.6)
<100 min 13/206 (6.3) 6/211 (2.8)
Cardiopulmonary bypass time .014
>180 min 28/274 (10.2) 9/165 (5.5)
<180 min 9/182 (4.9) 6/182 (3.3)
Aortic valve or root procedures .955
Aortic valve repair 3/63 (4.8) 0/22 (0) .243
Repair of sinus of Valsalva 2/19 (10.5) 0/6 (0) 1.000
David procedure 0/1 (0) 0/0 (0) 1.000
Aortic valve replacement 0/5 (0) 0/5 (0) .402
Wheat procedure 1/2 (50.0) 0/6 (0) .487
Cabrol procedure 0/1 (0) 0/5 (0) .518
Bentall procedure 13/130 (10.0) 6/119 (5.0) .373
None 18/235 (7.7) 9/184 (4.9) .955
Concomitant procedures <.001
Yes 9/53 (17.0) 9/49 (18.4)
No 28/403 (6.9) 6/298 (2.0)
Coronary artery bypass grafting .001
Yes 6/43 (14.0) 5/24 (20.8)
No 31/413 (7.5) 10/323 (3.1)
Mitral valve repair/replacement .976
Yes 0/2 (0) 1/13 (7.7)
No 37/454 (9.0) 14/334 (4.2)
Extra-anatomic bypass <.001
Yes 5/11 (45.5) 4/16 (25.0)
No 32/445 (7.2) 11/331 (3.3)
Data presented as deaths/total patients (%).
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Univariate analysis identified 16 variables associatedwith
operative mortality and showed that the risk of operative
mortality after the Sun procedure in those with acute
TAADwas 1.95 times greater than that in thosewith chronic
TAAD (odds ratio [OR], 1.95; 95% confidence interval [CI],
1.00-3.63; P ¼ .031; Table 6). However, multivariate anal-
ysis failed to identify acuity as a risk factor (OR, 1.67;
95%CI, 0.83-3.38; P¼ .152). The risk factors for operative
mortality were previous cerebrovascular disease (OR, 7.01;
95% CI, 2.16-22.73; P ¼ .001); malperfusion of the brain
(OR, 7.10; 95% CI, 2.08-24.21; P ¼ .002), kidneysrdiovascular Surgery c Volume 148, Number 3 967
TABLE 7. Difference in operative mortality between acute and
chronic groups was not affected by acuity of aortic dissection but by
7 other risk factors
Variable OR 95% CI P value
Group (acute vs chronic) 1.67 0.83-3.38 .152
Previous cerebrovascular disease 7.01 2.16-22.73 .001
Spinal cord malperfusion 22.79 2.27-228.97 .008
Visceral malperfusion 22.98 3.23-163.38 .002
Renal malperfusion 12.67 2.11-75.97 .005
Cerebral malperfusion 7.10 2.08-24.21 .002
Extra-anatomic bypass 9.50 3.25-27.81 <.001
Cardiopulmonary bypass time 1.01 1.00-1.016 <.001
Coronary malperfusion 4.50 1.00-20.22 .050
OR, Odds ratio; CI, confidence interval.
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(OR, 22.79; 95% CI, 2.27-228.97; P ¼ .008), and viscera
(OR, 22.98; 95% CI, 3.23-163.38; P ¼ .002); concomitant
extra-anatomic bypass (OR, 9.50; 95% CI, 3.25-27.81;
P< .001); and CPB time>180 minutes (OR, 1.01; 95%
CI, 1.00-1.016; P < .001). Coronary malperfusion may
also affect operative mortality (OR, 4.50; 95% CI,
1.00-20.22; P ¼ .050; Table 7).DISCUSSION
During the past 2 decades, the surgical outcomes of
TAAD have improved considerately and various techniques
have been proposed for surgical repair. However, the
operative mortality has remained high, and several aspects
of surgical management remain controversial. The most
important issue is the extent of distal aortic repair4-6 (ie,
the use of a limited approach such as ascending/hemiarch
repair6 or an extensive approach such as the FET
technique8). Although it has been used more widely,8,10
the safety of FET in the acute setting remains debated,24
owing to its technical complexity and longer cerebral
perfusion and circulatory arrest times, which might increase
the risk of mortality and neurologic events.12,13 Another
important concern is that surgical repair in the acute
phase of TAAD was reported to be associated with greater
operative mortality than in the chronic phase.1 The present
study of the early outcomes after the Sun procedure in a
large series of 803 patients with acute and chronic TAAD
is helpful in addressing these 2 important issues.
First, the present study addressed the issue of the safety of
the FET technique in patients with TAAD. The overall
operative mortality was 6.5%, and the incidence of stroke
and spinal cord injury was 2.0% and 2.4%, respectively.
Except for respiratory morbidities, other postoperative
complications such as renal failure, reexploration for
bleeding, recurrent nerve injury, and limb ischemia were
consistently infrequent, occurring in only 3.3%, 3.1%,
1.1%, and 0.9% of all patients, respectively. These early
results have indicated that the Sun procedure is a safe968 The Journal of Thoracic and Cardiovascular Surgsurgical approach for patients with acute and chronic
TAAD and will possibly pave the way for wider use of
the FET technique.24 Moreover, in our previous series of
148 patients with acute TAAD, we achieved a mortality
of only 4.7%, which compared favorably with that of a
similar group of patients undergoing hemiarch repair,
with a mortality of 6.1%.19 Uchida and associates9 also
reported that the FET technique could be performed
safely for acute TAAD and might reduce the need for
reintervention on the residual false lumen. The results of
both studies argue in favor of wider use of the extensive
FETwhen determining the extent of distal repair for patents
with TAAD.
Second, although the operative mortality of the Sun
procedure was significantly greater in the acute group
than in the chronic group (8.1% vs 4.3%, P ¼ .031),
multivariate analysis proved that acuity did not affect
operative mortality (OR, 1.67; 95% CI, 0.83-3.38;
P ¼ .152) in this cohort. This is in agreement with the
conclusion of Sabik and colleagues25 that the acuity of
dissection was not a risk factor for early mortality. In the
present series of 803 patients with TAAD, the risk factors
for operative mortality after the Sun procedure were
previous cerebrovascular disease, malperfusion syndrome
(including cerebral, renal, spinal cord, and visceral
ischemia), extra-anatomic bypass, and a CPB time>180
minutes. These results imply that, in the absence of these
risk factors, performing emergency FET with total arch
replacement in the setting of acute TAAD will not impose
a greater risk of operative mortality compared with an
identical procedure performed electively in the setting of
chronic TAAD. The present results add evidence that
cardiovascular surgeons can safely use this more aggressive
FET technique with total arch replacement for cases of
acute type A dissections without the fear of worse outcomes
for the patient. Because devices and systems are evolving
toward an ideal open stent graft, with the accrual of
evidence from registry data with longer follow-up,26 FET
with total arch replacement could become the next standard
of care for patients with TAAD for whom arch repair is
required.8,15,16,27
The results of the present study have shown that FETwith
total arch replacement is not associated with greater early
mortality andmorbidity compared with totally conventional
techniques. One of the reasons for such favorable outcomes
might be the special FET used in this procedure, the Cronus
(MicroPort Medical Co, Ltd). It can be implanted very
easily and quickly, thereby decreasing the circulatory arrest
time, as evidenced by the cerebral perfusion time of 25  8
minutes in the present series, which was much shorter than
the weighted value of 52  31 minutes in the meta-analysis
by Tian and associates.10 The technical simplicity results in
a lower learning curve, which is very important for the
wider and quicker spread of this approach in regions withery c September 2014
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and distal ends make anastomosis easier, which help
minimize the risk of proximal endoleak and facilitate
manipulations in subsequent operations, should any be
required.16 An algorithm dictating surgical strategies using
our subcategorization of the Stanford system that divides
TAAD into subtypes might also have contributed to the
better results of the Sun procedure.19
Focusing on the effect of patient age on outcome, we
failed to identify age as a risk factor for operative mortality,
similar to the results of Chiappini and associates.28 The
most likely reason for this paradoxical finding is the
predominance of younger patients in our series, with only
90 of 803 patients (11.2%) aged 60 years. In contrast,
one third of the patients in the International Registry of
Aortic Dissection29 and 29.9% in the German Registry
for Acute Aortic Dissection Type Awere aged70 years.30
However, in contemporary FET cohorts, the patients have
also been relatively young, with a mean age of 45 to 61
years, irrespective of geographic differences.10,31,32 In a
group of 355 patients with acute TAAD, Kimura and
associates33 found that the early and late surgical outcomes
were not better in patients aged 45 years, with an
increased risk of reoperation, possibly because ascending
aortic or hemiarch replacement was performed in>80%
of the patients. Their results conversely imply that the
more extensive FET procedure should be chosen for
younger patients.
Malperfusion phenomena have an incidence of 16% to
33%, and clinically apparent malperfusion of any type
increases the mortality risk.3,34,35 In the present cohort, 4
of the 7 risk factors for operative mortality belonged to
malperfusion syndrome, which occurred in 88 patients
(10.9%) and led to a mortality of 19.3%, with even
greater mortality (25.0%) in the acute group. Of all
malperfusion phenomena, visceral malperfusion is the
most lethal, heralding an extremely poor prognosis,3 as
evidenced by a mortality of 71.4% (5 of 7) and a 23-fold
increased risk of death (OR, 22.98). Spinal cord
malperfusion carried almost the same risk (OR, 22.79),
with a death rate of 50.0% (2 of 4). Renal malperfusion
often responds well to aortic repair3 but increased the risk
of death by 12.67 times in the present series, with a
mortality of 42.8% (3 of 7). With an OR of 4.50, the effect
of coronary malperfusion needs to be further validated in a
larger sample with more events (P ¼ .050). The results of
the present study have highlighted the malignant effect of
malperfusion on the clinical outcome of patients with
TAAD. In many patients, malperfusion itself is an
indication for aortic repair, which is expected to save life
and reperfuse the ischemic organs. In some cases,
reperfusion necessitates concomitant procedures, which
will inevitably entail longer CPB, crossclamp, and
circulatory arrest times, thus forming a vicious cascade ofThe Journal of Thoracic and Ca‘‘malperfusion/ concomitant procedure/ longer time
of CPB, crossclamp, and circulatory arrest / higher
mortality.’’ This has been corroborated by the results of
multivariate analysis, in which malperfusion (of 4
organs), extra-anatomic bypass (to correct malperfusion),
and the resultant longer CPB time were all identified as
independent risk factors for operative mortality.
The present retrospective study had several limitations.
First, >80% of our patients had been diagnosed at
peripheral or remote hospitals and transferred for a long
distance to our institution. Many patients with severe
TAAD died of aortic rupture, tamponade, or malperfusion
during transfer, while in the emergency room, or even while
awaiting surgical repair. Thus, we were treating a group of
less severe patients who had survived the initial attack of
aortic dissection. Second, our patients were young, with a
mean age of 46 years and only 11.2% of them aged
60 years, in contrast to the International Registry of Aortic
Dissection29 and German Registry for Acute Aortic
Dissection Type A30 registries in which29.9% of patients
were aged 70 years. In the European series, the patients
are ‘‘all comers,’’ with most of them presenting within the
first few hours of dissection. In contrast, only 6.6% of our
patients with acute TAAD presented within the first 10
hours of onset. Therefore, it was very difficult to make
direct comparisons between our data and those from Europe
and North America. Third, the results of the present study
were certainly influenced by the vast experience gained
by our group, which is the largest aortic surgical center in
China, with an annual case volume of 1100. Such favorable
conditions are not commonly found or replicated elsewhere.
Most importantly, data of late survival and freedom from
late distal reintervention were limited, and our efforts
with long-term follow-up of patients are ongoing.CONCLUSIONS
In the present group of patients with TAAD, acuity was
not a risk factor for operative mortality of frozen elephant
trunk and total arch replacement (the Sun procedure).
Patients with previous cerebrovascular disease; mal-
perfusion of the brain, kidneys, spinal cord, and viscera;
concomitant extra-anatomic bypass, and longer cardio-
pulmonary bypass time (>180 minutes) had a greater risk
of operative mortality.References
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Dr Malakh Lal Shrestha (Hannover, Germany). I want to
congratulate you on your excellent presentation. Since Hans Borst
did the first elephant trunk in 1982 in Hannover, the indications
have obviously been expanded.
In 1989, our co-chair of this session, Professor Sch€afers,
performed the first elephant trunk implantation in acute aortic
dissection. Since 2001, we have been doing the same as what
you have been doing here, initially as a bailout procedure in the
DeBakey type I dissection with intimal tears in the distal arch or
proximal descending aorta. However, with more experience, we
have also expanded our indications to clinically stable young
patients with DeBakey type I dissections even without intimal
tears or reentry in the distal arch or descending aorta.
As a high-volume center, what we have learned is that patients
with acute and chronic aortic dissection are 2 totally different
subsets of patients in terms of clinical presentation and mortality.
The greatest danger to the patient with acute aortic dissection is
during the first few hours immediately after the dissection, with
most patients dying without surgical intervention.
In Germany, owing to the small geographic size compared with
the United States and also to excellent emergency services, we
receive patients within the first hour, sometimes 2 hours. Even
then, when we operate, the mortality is still high. Also, we saw
in the Aortic Symposium in New York that the German database
shows that in >3000 patients, a difference in mortality exists
whether you do an ascending aortic replacement or the FET; that
is, a 10% difference, and it was 24% with FETs.
So, I would like to ask you a couple of questions. First, what is
the duration in your case series from the occurrence of dissectionery c September 2014
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within the first few hours?
The second question is, does your series include all comers, or
was there some sort of preselection? Because if the patients come
later on, whether you operate on them later or the patients are
arriving later, it might be in terms of classification acute, but if
they come after 4 days, that is a large difference from patients
coming in the first day. Thank you.
DrMa. Thank you for your comments and questions. You have
made inquiries on an important issue of our study. I am not sure if
I understood your second question correctly, but I have an answer
to your first question.
Please take a look at this table (in slide 6). The first line is
the time from the onset of symptoms to the diagnosis. It was
3.2 3.1 days on average in the acute group. In the chronic group,
the mean time was almost 190 days.
The second line is the duration from diagnosis to surgery. It
averaged 2 days, and the median timewas 1 day in the acute group.
So, most acute patients would have had to wait for 1 day before
surgery.
The third line is the time from symptom onset to surgery, which
was 5.0  3.8 days in the acute group, with a median time of 4
days.
Dr Shrestha. So that means that on the basis of classification,
you can still say it is acute. But there has been some sort of
‘‘natural selection.’’ So that means, I think at least for the title or
the conclusion, you need to qualify the statement saying that no
difference exists between acute and chronic, because it is
obviously not the same subset of patients that we see in the
Western world.
Dr Ma. Yes. Because about 80% of our patients were referrals,
they were transferred from hundreds of miles away or even more
remote areas. Therefore, many patients expired on the way to
our hospital, in the emergency room, or even while awaiting
surgery in the operating room. That is a result of natural selection.
Dr Shrestha. So that means that you would agree with me that
in conclusion one cannot say that no difference exists between
patients with acute and chronic type A dissection in terms of
mortality, right? Because from the onset to surgery was 5 days
or 5.5 on average; thus, it was not all comers. So perhaps if you
are operating on patients on the first day, that is different than
operating on these type of patients?
Dr Ma. Yes. If the patient could be operated on immediately
after their arrival at the hospital, the operative mortality might
increase.
Dr Shrestha. Thank you.
Dr D. Craig Miller (Stanford, Calif). This was, again, another
wonderful presentation by DrMa of Dr Sun’s vast experience. As I
asked Dr Sun a few days ago in New York at the Thoracic Aortic
Summit, I continue to be totally flummoxed by why the average
age here is 46, and even younger, for those with acute type A
dissection. He answered that this was because of the many patients
with severe hypertension. Clearly, they probably have an
extremely high incidence of aortic dissection in China.
Respectfully, I still just do not understand this skewing of the
population, meaning that the patients that arrive at your center in
Beijing are so young. Is it because of economic reasons that the
older patients are not being transferred to your hospital or notThe Journal of Thoracic and Caundergoing surgery? Dr Sun told me in New York that the patients
come from 1000, 2000, 3000 km away. Obviously, a lot of natural
selection must be occurring just with a natural piece to the disease.
I wonder if an economic selection is also occurring, such that only
the younger middle class have the financial resources to reach your
center and undergo surgery. I just do not understand why you have
an average age that is 20 years younger than the European,
North American, and South American series of acute type A
dissection.
DrMa. I think hypertension is a disease related to the change in
lifestyles and environment associated with rapid economic
development and social alterations. Nowadays, many young
people in China smoke tobacco and drink, they are obese and
lack physical exercise, and many patients simply do not know
they have hypertension at all. Also, even if some people know
they have hypertension, their hypertension is not well controlled.
Of course, there are many patients with Marfan syndrome or other
connective tissue disorders as well. However, many of the elderly
in China fortunately did not go through these rapid changes in
lifestyle and environment that many young people have to
experience. Thus, there are fewer seniors over 60 who suffered
from hypertension, which also contributes to the predominance
of young patients. I should note that there was no economic factor
when we made treatment decisions for the older patients.
Dr Miller. In Japan, they also are very hypertensive, but their
age of dissection is older than even in Europe and North America.
I simply do not understand this skewed patient population; there
must be other factors involved.
But, my main point here today is I think we have to move
beyond the fact that ‘‘it can be done,’’ which Dr Sun and others
have demonstrated. We have to determinewhich patient with acute
type A dissection should undergo distal FET. Should it be just be
those with a connective tissue disorder, who probably are at higher
risk of late downstream aortic complications? Second, there is no
‘‘free lunch’’ here: we have to justify the increased risk (mainly
paraplegia and death) incurred when one does something at the
initial operation downstream in the descending aorta. In the large
German Registry for Acute Aortic Dissection Type A registry, if
the arch was replaced (with or without concomitant FET)
electively without a compelling reason to do so, a 10% increment
occurred in the operative mortality rate. So the main questions is
whom should it be done in, not just can it be done safely. Does
that make any sense to you?
Dr Ma. We have already initiated a study on those young
patients 3 years ago and are seeking to identify some genetic
causes in those younger patients. Also, we are striving to set up
aortic surgical training centers across China, so that patients will
not have to travel such a long distance to receive appropriate
surgical management. In addition, our colleagues in cardiology
and other specialties are trying hard to educate patients to have
adequate control of their blood pressure.
Regarding which patients should undergo distal FET, we
believe that those patients who are young, who are unlikely to
come back for subsequent intervention on downstream aorta,
and who are at continuing risk for distal aortic dilation and dissec-
tion (such as Marfan syndrome) may benefit most from the Sun
operation because of the specifics of the Chinese patient popula-
tion, their lifestyles, and risk factors.rdiovascular Surgery c Volume 148, Number 3 971
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and subacute type A dissection; your point that these cases were
not chronic dissections (many years after the initiating event) is
important. How many of all these cases did not undergo a Sun
procedure or distal FET?
Dr Ma. Because most of those patients were transferred from
remote or peripheral hospitals, those peripheral or local hospitals
might have kept the easier cases and referred those more
complicated cases to us. That is 1 point.
Another point is, before 2009, we tended to do simpler
operations, such as the hemiarch repair. Let me show you here
on this slide (slide 16).
In this group of patients, 148 patients with acute dissection
who underwent a Sun operation. The mortality after the Sun
operation was 4.7%. In a similar group of 66 patients with acute972 The Journal of Thoracic and Cardiovascular Surgtype A dissection who had a hemiarch repair, the mortality was
6.1%.
Dr Miller. What about today, does anybody not receive a Sun
procedure at your center?
Dr Ma. Yes. If a patient with type A dissection does not have
any of these 5 indications for the Sun procedure (listed on this slide
[slide 7]), this patient will receive a different operation.
Dr Miller. A simpler operation?
Okay.Howmanyof these patients did youhave in the sameperiod?
Dr Ma. As far as I can recall, the number was approximately
300. We looked it up in our database last year. There were about
300 such patients.
Dr Miller. So you do both, okay. Some day I will understand
why they are so young. Thank you.
Dr Ma. Thank you.ery c September 2014
